
What patients fail to understand when they sign up for genetic studies
As genetic sequencing becomes more widespread, a disconnect is emerging between what individual patients expect to get back and what scientists are willing and able to tell them. WSJ visited MIT's Broad Institute to learn about the murky world of genomic research data. Photo: Angela Weiss/AFP via Getty Images
UP NEXT
UP NEXT
-
Disney World's Epcot is getting a massive overhaul. Here's what it'll look like
CNBC
-
American Dream mall opens first indoor, year-round ski slope
Fox Business
-
Inside the opioid industry's marketing machine
The Washington Post
-
Big companies under pressure in tense IPO market
CNBC
-
How to turn down an interview without burning a bridge
Veuer
-
The 3 wealthiest countries in the world
24/7 Wall St.
-
German industry slump sparks renewed growth fears
Reuters
-
In the shadow of Austin, Texas, a small farm looms large
CBS News
-
Jim Cramer: Five Below is the first company making money off the tariffs
CNBC
-
College majors students regret the most
Veuer
-
How a math whiz built a $700 million fortune without humans
Bloomberg
-
The $3.7 trillion corporate debt question
The Wall Street Journal.
-
OPEC leaders meet in Vienna for crucial meeting
CNBC
-
How job seekers can take advantage of the holiday season
CBS News
-
How will December tariffs impact shoe prices?
Fox Business
-
Japan launches $122 billion stimulus package
Reuters
-
House overwhelmingly passes bill to combat robocalls
Newsy
-
Patrón Tequila sells a bottle for up to $7,500 — here's why the brand is so expensive
Business Insider
-
This is where some of the world's richest men shop for clothes
CNBC
-
What $1,000 in stocks invested during the last recession would be worth today
GOBankingRates
-
2019 gun background checks set to break record
Veuer
-
Why new Alphabet CEO Sundar Pichai may have most difficult job in Silicon Valley
CNBC